Skip to main content

Table 5 Visfatin inhibitors and stimulators

From: Novel targets for potential therapeutic use in Diabetes mellitus

Stimulators and inhibitors of Visfatin

Stimulators

Inhibitors

Reference

Hypoxia, Hyperglycemia, Inflammation, TNF-alpha, IL-6, IL-1 beta, Chronic Kidney Disease, Labor/Pregnancy, PCOS(polycystic ovary syndrome), Cancer, HAART (highly active antiretroviral therapy), Spironolactone, CoCl2 (hypoxia mimetic agent)

Macrostemonoside A

Insulin, Somatostatin, Monounsaturated fatty acid (e.g. oleate)

[89]